Dave HodesSeptember 30, 2022
To broaden the appeal of therapist-assisted psychedelics, a number of companies are engineering out the hallucinogenic aspect.
Tag: Delix Therapeutics
Dave HodesSeptember 30, 2022Dave HodesJune 2, 2022
The psychedelic experience is intense. As much as it can help someone understand and work through their mental health issues, the hallucinations that come with them are a significant part of the psychedelics experience that is what makes psychedelics the powerful and effective therapy that it is. But as the industry evolves and looks to […]
StaffSeptember 27, 2021
Delix Therapeutics closed on a $70 million Series A financing round. The company said it expects to use the money to advance two lead candidates through Phase 1 clinical trials, further expand its drug discovery platform of novel neuroplasticity-promoting compounds known as psychoplastogens, and expand its team. “We appreciate the overwhelming support from new and […]
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.